DTB select: Risk of DKA with SGLT2 inhibitors

Summary and context are provided for a cohort study (n=903,016) which found the risk of hospitalisation with DKA was almost three times higher in people taking SGLT2 inhibitors than in those taking DPP-4 inhibitors (2.0 vs 0.75 cases per 1000 person-years).

Source:

Drug and Therapeutics Bulletin